Stock listing

Stuttgart:19KA CorMedix Inc. Aktie

German listing (Stuttgart) of CorMedix Inc. · home listing NASDAQ:CRMD

Follow CorMedix Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CRMD

$5.27 USD +0.77 (+17.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CRMD

Past year -45.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.95 – $5.32 USDNov 20, 2026
Volume
3.61M sharesNov 20, 2026
Market cap
$410.8M USDAt the close on Nov 20, 2026 · price × 77.94M shares outstanding
52-week range
$4.49 – $13.02 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$9.34M USDMedian day 1.09M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
CorMedix Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CRMD · Home$5.27 USD+0.77 (+17.1%)3,608,270$4.96$5.315$4.95$4.50Close on Nov 20, 2026
Frankfurt:19KA€4.659 EUR+0.426 (+10.1%)—€4.415€4.659€4.415€4.233Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CRMD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.27+0.77+17.1%$4.96$5.315$4.953,608,270
$4.50-0.17-3.6%$4.65$4.71$4.4851,589,502
$4.67-0.15-3.1%$4.79$4.87$4.6351,987,052
$4.82+0.16+3.4%$5.05$5.233$4.753,195,451
$4.66-0.18-3.7%$4.88$5.055$4.652,391,229
$4.84-0.46-8.7%$5.15$5.49$4.8153,675,346
$5.30-0.07-1.3%$5.33$5.42$5.241,618,545
$5.37-0.10-1.8%$5.49$5.67$5.292,341,388
$5.47+0.15+2.8%$5.47$5.56$5.162,325,920
$5.32+0.09+1.7%$5.25$5.34$5.101,616,500
$5.23-0.43-7.6%$5.75$5.77$5.211,829,300
$5.66+0.10+1.8%$5.71$5.79$5.581,491,200
$5.56+0.17+3.2%$5.35$5.60$5.302,456,900
$5.39-0.31-5.4%$5.70$5.75$5.343,303,800
$5.70-1.94-25.4%$7.68$7.68$5.637,014,600
$7.64-0.56-6.8%$8.34$8.35$7.461,886,200
$8.20+0.20+2.5%$7.95$8.22$7.901,156,800
$8.00+0.06+0.8%$7.91$8.11$7.801,002,300
$7.94+0.09+1.1%$8.06$8.09$7.761,130,300
$7.85-0.25-3.1%$8.01$8.11$7.79894,300
$8.10+0.31+4.0%$7.86$8.12$7.761,092,000
$7.79+0.22+2.9%$7.55$7.85$7.511,049,200
$7.57+0.19+2.6%$7.38$7.61$7.38971,100
$7.38+0.12+1.7%$7.26$7.57$7.251,471,900
$7.26-0.20-2.7%$7.47$7.47$7.241,140,400
$7.46+0.07+0.9%$7.49$7.70$7.431,466,200
$7.390.000.0%$7.36$7.53$7.271,124,900
$7.39-0.07-0.9%$7.43$7.55$7.331,415,700
$7.46+0.08+1.1%$7.41$7.60$7.161,592,000
$7.38+0.06+0.8%$7.32$7.46$7.261,194,400
$7.32+0.04+0.5%$7.28$7.36$7.181,018,300
$7.280.000.0%$7.27$7.31$7.18833,000
$7.28+0.02+0.3%$7.38$7.40$7.13744,300
$7.26+0.07+1.0%$7.18$7.33$7.061,256,000
$7.19-0.23-3.1%$7.45$7.45$7.171,125,200
$7.42-0.28-3.6%$7.65$7.69$7.401,051,100
$7.70-0.23-2.9%$7.95$7.95$7.66948,400
$7.93+0.04+0.5%$7.91$7.96$7.82817,400
$7.89+0.04+0.5%$7.77$7.90$7.77485,000
$7.85+0.08+1.0%$7.79$7.90$7.69606,600
$7.77+0.08+1.0%$7.70$7.79$7.62946,500
$7.69-0.09-1.2%$8.03$8.19$7.63812,400
$7.78+0.01+0.1%$7.83$7.83$7.69788,900
$7.77+0.05+0.6%$7.72$7.82$7.62505,700
$7.72-0.07-0.9%$7.65$7.79$7.621,806,500
$7.79-0.03-0.4%$7.86$7.92$7.70684,700
$7.82+0.06+0.8%$7.78$7.87$7.72664,400
$7.76-0.13-1.6%$7.90$7.90$7.71717,700
$7.89+0.06+0.8%$7.83$7.95$7.75920,200
$7.83-0.13-1.6%$8.04$8.06$7.82820,500
$7.96-0.17-2.1%$8.11$8.12$7.92857,300
$8.13-0.05-0.6%$8.18$8.33$8.08928,200
$8.18-0.25-3.0%$8.28$8.37$8.111,101,000
$8.43-0.04-0.5%$8.45$8.61$8.31792,800
$8.47-0.14-1.6%$8.69$8.75$8.43706,700
$8.61+0.23+2.7%$8.40$8.62$8.331,102,000
$8.38+0.12+1.5%$8.25$8.49$8.18880,400
$8.26-0.04-0.5%$8.26$8.29$8.06980,500
$8.30-0.01-0.1%$8.28$8.40$8.19775,800
$8.31-0.08-1.0%$8.49$8.49$8.28703,900
$8.39-0.17-2.0%$8.60$8.61$8.37865,400
$8.56+0.28+3.4%$8.35$8.575$8.281,235,615
$8.28+0.08+1.0%$8.28$8.495$8.181,012,332
$8.20-0.03-0.4%$8.29$8.41$8.161,496,600
$8.23-0.29-3.4%$8.49$8.54$8.191,006,400

Splits

1 split · NASDAQ:CRMD · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
Ticker
Stuttgart:19KA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

All CorMedix Inc. news

CorMedix Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
22 in the last 12 months · 170 in all · newest Nov 12, 2026 · oldest 2019
Calls
26 calls with a replay · 26 with a transcript · latest Nov 12, 2026
Decks
34 decks · latest Nov 10, 2026

Where CorMedix Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CRMD · Home listingNASDAQUnited StatesUSD
gettex:19KAgettexGermanyEUR
Tradegate:19KATradegateGermanyEUR
Stuttgart:19KA · This pageStuttgartGermanyEUR
LS Exchange:A2PF3GLS ExchangeGermanyEUR
BOATS:CRMDBOATSUnited StatesUSD
Lang & Schwarz:A2PF3GLang & SchwarzGermanyEUR
Frankfurt:19KAFrankfurtGermanyEUR
Munich:19KAMunichGermanyEUR
Dusseldorf:19KADusseldorfGermanyEUR
Hamburg:19KAHamburgGermanyEUR

Valuation

P/E 6.4× against a median of 35.7×: the lowest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$201.0M USD
P/E
6.4×
EV/sales
0.5×
EV/EBITDA
1.0×
Price/book
0.9×
Gross margin
77.5%
Operating margin
38.6%
Net margin
15.5%
Debt to equity
0.3×
Beta vs S&P 500
0.71

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CorMedix Inc. · NASDAQ:CRMDUS$410.8MUS$201.0M6.4×0.5×1.0×0.9×15.5%0.3×0.71
Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A · SSE:603811US$426.4MUS$399.3M15.0×3.2×n/a1.9×22.8%0.0×n/a
Harbin Medisan Pharmaceutical Co., Ltd. Class A · SZSE:002900US$413.1MUS$377.4Mn/a3.0×n/a1.6×−27.1%0.1×n/a
PKU Healthcare Corp. Ltd. Class A · SZSE:000788US$412.4MUS$243.9M133×1.8×n/a1.8×2.3%0.0×n/a
Huaren Pharmaceutical Co., Ltd. Class A · SZSE:300110US$409.9MUS$445.4Mn/a2.4×n/a3.2×−40.2%0.5×n/a
Handa Pharmaceuticals Inc · TPEX:6620US$405.8MUS$292.6M27.3×8.0×15.6×2.7×40.5%0.0×n/a
ScinoPharm Taiwan, Ltd. · TWSE:1789US$404.2MUS$324.5M797×3.5×n/a1.3×0.5%0.1×n/a
Zhuhai Rundu Pharmaceutical Co. Ltd. Class A · SZSE:002923US$401.6MUS$381.7M47.1×1.9×n/a2.4×4.2%0.2×n/a
Cheng Du Sheng Nuo Biotec Co., Ltd. Class A · SSE:688117US$398.5MUS$406.8M12.7×2.8×n/a2.3×21.8%0.3×n/a
Kexing Biopharm Co., Ltd. Class A · SSE:688136US$398.1MUS$410.5M35.7×2.1×n/a1.5×5.7%0.4×n/a
Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A · SSE:603139US$393.1MUS$396.8Mn/a5.1×n/a3.9×−38.4%0.2×n/a
Median of the othersUS$405.0MUS$389.3M35.7×2.9×15.6×2.1×3.2%0.2×

Forecasts

3 strong buy · 3 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
14.83 USD · Analysts' mean
EPS, year to Dec 2026
0.49 · 1 analyst
Revenue, year to Dec 2026
336.8M · 6 analysts

Team and board

Officers

OfficerRole
Joe TodiscoChief Executive Officer and Chairman
Susan BlumEVP & Chief Financial Officer
Liz HurlburtEVP, Chief Operating & Commercial Officer
Beth Zelnick KaufmanEVP, Chief Legal and Compliance Officer, and Corporate Secretary
Mike SecklerEVP & Chief Commercial Officer

Board

DirectorRole
Joe TodiscoChief Executive Officer and Chairman
Alan W. DuntonDirector
Greg DuncanDirector
Janet D. DillioneDirector
Myron KaplanLead Independent Director
Robert StewartDirector
Steven LefkowitzDirector

Events

Calls

CallWhenStatus
CorMedix (NASDAQ:CRMD) Q3 2026 Earnings CallThu, Nov 12, 2026 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2026 Earnings CallThu, Aug 13, 2026 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2026 Earnings CallThu, May 14, 2026 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q4 2025 Earnings CallThu, Mar 05, 2026 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2025 Earnings CallWed, Nov 12, 2025 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2025 Earnings CallThu, Aug 07, 2025 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2025 Earnings CallTue, May 06, 2025 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2024 Earnings CallWed, Oct 30, 2024 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2024 Earnings CallThu, May 09, 2024 · 8:30 AM ETReplay
All 26 calls
CallWhenStatus
CorMedix (NASDAQ:CRMD) Q4 2023 Earnings CallTue, Mar 12, 2024 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2023 Earnings CallTue, Nov 14, 2023 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2023 Earnings CallMon, May 15, 2023 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q4 2022 Earnings CallThu, Mar 30, 2023 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2022 Earnings CallThu, Nov 10, 2022 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2022 Earnings CallThu, Aug 11, 2022 · 8:30 AM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2022 Earnings CallThu, May 12, 2022 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q4 2021 Earnings CallTue, Mar 29, 2022 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2021 Earnings CallThu, Aug 12, 2021 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2021 Earnings CallThu, May 13, 2021 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q4 2020 Earnings CallTue, Mar 30, 2021 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q3 2020 Earnings CallThu, Nov 05, 2020 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q2 2020 Earnings CallMon, Aug 10, 2020 · 4:30 PM ETReplay
CorMedix (NASDAQ:CRMD) Q1 2020 Earnings CallMon, May 11, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026 · Before open−8.7%
Q2 2026Aug 13, 2026 · Before open+14.7%
Q1 2026May 14, 2026 · Before open+5.7%
Q4 2025Mar 31, 2026+6.8%
Q3 2025Nov 12, 2025 · Before open+2.1%
Q2 2025Aug 7, 2025 · Before open−9.5%
Q1 2025May 6, 2025 · Before open+23.6%
Q4 2024Mar 10, 2025 · Before open+0.2%
Q3 2024Oct 30, 2024 · Before open−22.5%
Q2 2024Aug 14, 2024 · Before open+30.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · Before open−5.2%
Q4 2023Mar 12, 2024 · Before open−2.8%
Q3 2023Nov 14, 2023 · After close+6.4%
Q2 2023Aug 8, 2023 · Before open+7.9%
Q1 2023May 15, 2023 · After close−13.4%
Q4 2022Mar 30, 2023 · Before open+13.1%
Q3 2022Nov 10, 2022 · Before open+9.2%
Q2 2022Aug 11, 2022 · Before open+10.1%
Q1 2022May 12, 2022 · After close+9.7%
Q4 2021Mar 29, 2022 · After close+5.6%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (November 2026)Merger or acquisition7 slidesNov 10, 2026
Merger or Acquisition (November 2026)Merger or acquisition7 slidesNov 9, 2026
Technical Presentation (October 2026)Technical16 slidesOctober 2026
CorMedix Therapeutics — Investor Presentation (September 2026)Investor deck25 slidesSeptember 2026
CorMedix Therapeutics — Investor Presentation (May 2026)Investor deck24 slidesMay 2026
Investor Presentation (March 2026)Investor deck23 slidesMar 6, 2026
CorMedix Therapeutics — Investor Day (February 2026)Investor day50 slidesFeb 10, 2026
CorMedix Therapeutics — J.P. Morgan Healthcare Conference 2026Conference23 slidesJanuary 2026
Investor Presentation (September 2025)Investor deck19 slidesSeptember 2025
Q2 2025 Earnings PresentationEarnings8 slidesAug 7, 2025
All 34 decks
DeckKindSlidesDate
Q1 2025 Earnings PresentationEarnings24 slidesMay 6, 2025
Investor Presentation (January 2025)Investor deck32 slidesJan 10, 2025
Investor Presentation (August 2024)Investor deck32 slidesAug 14, 2024
Investor Presentation (June 2023)Investor deck22 slidesJune 2023
Investor Presentation (May 2023)Investor deck22 slidesMay 2023
Investor Presentation (January 2023)Investor deck17 slidesJanuary 2023
Investor Presentation (November 2022)Investor deck17 slidesNovember 2022
Investor Presentation (June 2022)Investor deck15 slidesJun 15, 2022
Investor Presentation (February 2022)Investor deck20 slidesFeb 28, 2022
Investor Presentation (April 2021)Investor deck21 slidesApril 2021
Investor Presentation (September 2020)Investor deck21 slidesSep 1, 2020
Investor Presentation (January 2020)Investor deck21 slidesJanuary 2020
Cantor Global Healthcare Conference 2019Conference26 slidesOct 3, 2019
21st Annual H.C. Wainwright Global Investment Conference (September 2019)Conference23 slidesSep 9, 2019
Technical Presentation (May 2019)Technical29 slidesMay 10, 2019
Oppenheimer 29th Annual Healthcare Conference 2019Conference19 slidesMar 19, 2019
Investor Presentation (March 2019)Investor deck26 slidesMarch 2019
Investor Presentation (January 2019)Investor deck23 slidesJanuary 2019
Investor Presentation (September 2018)Investor deck23 slidesSeptember 2018
Investor Presentation (December 2017)Investor deck24 slidesDecember 2017
Investor Presentation (September 2017)Investor deck22 slidesSeptember 2017
Investor Presentation (April 2015)Investor deck7 slidesApr 9, 2015
Investor Presentation (December 2013)Investor deck20 slidesDec 3, 2013
Investor Presentation (August 2013)Investor deck24 slidesAug 26, 2013

Open Decks

Financings

RaiseDate
Convertible debt
Closed: US$150M raised
Buyers: Deerfield
Use of proceeds: Funding the cash consideration for the acquisition of Melinta Therapeutics
Sep 2, 2025
Public offering of shares of common stock
Update: about US$85M · RBC Capital Markets +3
Dealers: RBC Capital Markets (lead), Truist Securities, Citizens Capital Markets, Needham & Company
Use of proceeds: General corporate purposes, including working capital, research and product candidate development, and potential strategic transactions
Jun 27, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue311.7M43.5M065.4K190.9K239.2K283.3K429.8K329.3K224.1K
Cost of revenue22.1M3.03M205.6K3.73K148.9K204.8K373.2K396.8K115.0K366.7K
Gross profit275.7M40.3M-205.6K61.7K42.0K34.4K-90.0K33.0K214.4K-142.6K
Research and development19.3M3.94M13.2M10.7M13.1M13.4M11.1M18.8M24.5M15.7M
Selling, general and administrative68.2M30.0M35.8M20.0M16.3M13.9M9.87M8.07M8.65M8.88M
Operating income150.1M-22.4M-49.0M-30.6M-29.4M-27.2M-21.0M-26.9M-32.9M-24.8M
Depreciation and amortization677.0K154.0K70.8K84.6K61.9K128.0K73.3K74.2K36.9K25.6K
EBITDA150.8M-22.2M-48.9M-30.5M-29.4M-27.1M-20.9M-26.8M-32.9M-24.7M
Interest expense2.78M36.0K34.3K26.5K15.9K33.2K787.5K1.87K5.62K1.31K
Income before tax150.0M-19.3M-46.3M-30.3M-29.5M-27.2M-21.5M-26.8M-33.0M-24.6M
Income tax-13.0M-1.40M-2-585.6K-1.25M-5.17M-5.06M36.4K-31.3K1.31K
Net income163.1M-17.9M-46.3M-29.7M-28.2M-22.0M-16.4M-26.8M-33.0M-24.6M
Earnings per share, basic2.25-0.30-0.91-0.74-0.75-0.77-1.80-1.51-0.60-0.65
Earnings per share, diluted2.04-0.30-0.91-0.74-0.75-0.77-1.80-1.51-0.60-0.65

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents144.8M40.7M43.6M43.1M53.3M41.9M16.4M17.6M10.4M8.06M
Short-term investments3.69M11.0M32.4M15.6M12.1M4.44M12.0M01.60M12.1M
Receivables171.2M51.7M0045.4K3.36K3510.9K64.1K12.0K
Inventory29.7M7.60M2.11M03.01K143.6K338.5K428.5K594.2K166.7K
Current assets367.1M114.6M79.5M59.6M66.5M48.2M29.3M18.7M13.3M21.8M
Property, plant and equipment5.96M1.83M1.87M1.61M1.47M111.5K122.1K160.9K186.3K69.7K
Goodwill30.0M1.84B00
Total assets826.1M118.8M82.1M62.0M68.9M49.3M29.5M18.8M13.5M21.9M
Accounts payable7.88M1.72M4.28M2.20M2.21M1.13M1.02M2.59M1.81M1.65M
Current liabilities174.3M33.8M11.4M6.31M5.35M4.16M5.83M7.77M6.26M4.09M
Long-term debt144.6M6.13M00
Total debt148.9M517.0K667.6K802.4K923.8K1.03M4.69K6.13M
Total liabilities420.8M34.2M11.9M6.98M6.15M5.09M5.83M13.9M6.26M4.09M
Shareholders' equity405.3M84.7M70.1M55.1M62.8M44.2M23.6M4.93M7.19M17.8M
Shares outstanding79.3M64.4M54.9M42.8M38.1M33.6M25.7M21.8M71.4M40.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations175.0M-50.6M-38.4M-24.4M-21.2M-22.0M-15.1M-23.7M-28.6M-22.3M
Capital spending-2.26M-116.0K-327.3K-219.4K-1.43M-112.6K-36.6K-48.9K-152.0K-58.7K
Free cash flow172.8M-50.7M-38.7M-24.6M-22.6M-22.1M-15.1M-23.7M-28.7M-22.3M
Cash from investing-308.4M21.2M-17.1M-3.71M-9.13M7.43M-12.0M1.56M10.4M11.4M
Cash from financing238.5M26.3M55.9M17.9M41.8M40.1M25.8M29.4M20.5M7.09M
Dividends paid00
Share buybacks-198.4K41.8M40.1M26.0M22.0M20.5M7.09M
Change in cash105.1M-3.07M448.4K-10.2M11.5M25.6M-1.27M7.24M2.32M-3.75M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 20, 2026Insider tradeSEC
4 · Change in ownershipNov 20, 2026Insider tradeSEC
4 · Change in ownershipNov 18, 2026Insider tradeSEC
4 · Change in ownershipNov 16, 2026Insider tradeSEC
DFAN14ANov 13, 2026Other filingsSEC
DEFA14A · Additional proxy materialNov 13, 2026Meeting noticeSEC
8-K · Current reportNov 13, 2026Current reportSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
DEFA14A · Additional proxy materialNov 10, 2026Meeting noticeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportNov 10, 2026Current reportSEC
DEFA14A · Additional proxy materialNov 9, 2026Meeting noticeSEC
8-K · Current reportNov 9, 2026Material contractSEC
8-K · Current reportNov 2, 2026ResultsSEC
8-K · Current reportOct 19, 2026Current reportSEC
4 · Change in ownershipSep 18, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
8-K · Current reportAug 7, 2026Current reportSEC
8-K · Current reportJul 2, 2026Current reportSEC
8-K · Current reportJul 1, 2026Current reportSEC
S-8 POSJun 25, 2026Offer documentSEC
8-K · Current reportJun 24, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 12, 2026Big-stake noticeSEC
8-K · Current reportJun 8, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
8-K · Current reportApr 27, 2026Current reportSEC
PRE 14A · Preliminary proxy statementApr 17, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 6, 2026Current reportSEC
10-K · Annual reportMar 5, 2026Annual reportSEC
8-K · Current reportMar 5, 2026ResultsSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
4 · Change in ownershipJan 22, 2026Insider tradeSEC
144 · Notice of proposed saleJan 21, 2026Other filingsSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 14, 2026Insider tradeSEC
8-K · Current reportJan 8, 2026ResultsSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 2, 2026Big-stake noticeSEC
144 · Notice of proposed saleDec 30, 2025Other filingsSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
144 · Notice of proposed saleDec 18, 2025Other filingsSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
144 · Notice of proposed saleDec 9, 2025Other filingsSEC
144 · Notice of proposed saleDec 9, 2025Other filingsSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeDec 1, 2025Big-stake noticeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
144 · Notice of proposed saleNov 24, 2025Other filingsSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
144 · Notice of proposed saleNov 14, 2025Other filingsSEC
S-8 · Registration statement for employee plansNov 13, 2025Offer documentSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
4 · Change in ownershipOct 27, 2025Insider tradeSEC
DEF 14A · Proxy statementOct 24, 2025Meeting noticeSEC
8-K · Current reportOct 20, 2025ResultsSEC
PRER14AOct 14, 2025Other filingsSEC
S-3ASR · Registration statementOct 7, 2025Offer documentSEC
RW · Request to withdraw a registrationOct 7, 2025Other filingsSEC
S-3ASR · Registration statementOct 3, 2025Offer documentSEC
RW · Request to withdraw a registrationOct 3, 2025Other filingsSEC
S-3 · Registration statementSep 30, 2025Offer documentSEC
8-K/A · Current report, amendedSep 30, 2025Current reportSEC
4 · Change in ownershipSep 18, 2025Insider tradeSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementSep 15, 2025Meeting noticeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 12, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeSep 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
4 · Change in ownershipSep 11, 2025Insider tradeSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
4/A · Change in ownership, amendedSep 8, 2025Insider tradeSEC
4/A · Change in ownership, amendedSep 8, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
8-K · Current reportSep 2, 2025Acquisition or disposalSEC
8-K · Current reportAug 12, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 8, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
8-K · Current reportJun 30, 2025Current reportSEC
424B5 · ProspectusJun 30, 2025Offer documentSEC
424B5 · ProspectusJun 26, 2025Offer documentSEC
8-K · Current reportJun 25, 2025Meeting outcomeSEC
8-K · Current reportJun 23, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025ResultsSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2025Meeting noticeSEC
8-K · Current reportApr 22, 2025Current reportSEC
8-K · Current reportApr 8, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 4, 2025Big-stake noticeSEC
4 · Change in ownershipApr 3, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
10-K · Annual reportMar 25, 2025Annual reportSEC
8-K · Current reportMar 25, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2025Big-stake noticeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
4 · Change in ownershipJan 14, 2025Insider tradeSEC
8-K · Current reportJan 7, 2025ResultsSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4/A · Change in ownership, amendedDec 18, 2024Insider tradeSEC
4 · Change in ownershipDec 16, 2024Insider tradeSEC
4 · Change in ownershipDec 13, 2024Insider tradeSEC
8-K · Current reportNov 25, 2024Management or board changeSEC
4 · Change in ownershipNov 18, 2024Insider tradeSEC
144 · Notice of proposed saleNov 14, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportOct 30, 2024Quarterly reportSEC
8-K · Current reportOct 30, 2024ResultsSEC
DEF 14A · Proxy statementOct 8, 2024Meeting noticeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 14, 2024ResultsSEC
EFFECT · Notice that a registration is effectiveMay 23, 2024Other filingsSEC
CORRESP · Letter to the SECMay 20, 2024Other filingsSEC
UPLOAD · Letter from the SECMay 15, 2024Other filingsSEC
4 · Change in ownershipMay 13, 2024Insider tradeSEC
S-3 · Registration statementMay 9, 2024Offer documentSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 20, 2024Insider tradeSEC
4 · Change in ownershipMar 14, 2024Insider tradeSEC
10-K · Annual reportMar 12, 2024Annual reportSEC
8-K · Current reportMar 12, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 13, 2024Big-stake noticeSEC
8-K · Current reportJan 30, 2024Current reportSEC
SC 13G · Big-stake noticeJan 29, 2024Big-stake noticeSEC
4/A · Change in ownership, amendedJan 18, 2024Insider tradeSEC
4 · Change in ownershipJan 17, 2024Insider tradeSEC
4 · Change in ownershipJan 17, 2024Insider tradeSEC
4 · Change in ownershipJan 17, 2024Insider tradeSEC
4 · Change in ownershipJan 17, 2024Insider tradeSEC
4 · Change in ownershipDec 18, 2023Insider tradeSEC
8-K · Current reportDec 15, 2023Management or board changeSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 14, 2023Insider tradeSEC
4 · Change in ownershipNov 21, 2023Insider tradeSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
8-K · Current reportNov 16, 2023Current reportSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
8-K · Current reportNov 14, 2023ResultsSEC

This page holds 200 of 1,002 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from CorMedix Inc.’s releases · as of Sep 2, 2025

Common shares
77,944,324
Fully diluted
77,944,324

Fully diluted

LineShares
Common shares77,944,324

Share count over time

CountShares
Nov 22, 202677,944,324

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock6.45M8.1%US$49.7M+129KNov 13, 2026
Deep Track Capital, LP6.27M7.9%US$48.3MNo changeNov 16, 2026
Vanguard4.32M5.4%US$33.3M−101KNov 13, 2026
American Century2.72M3.4%US$21M+2.38MNov 20, 2026
State Street2.64M3.3%US$20.3M+321KNov 12, 2026
UBS2.36M3.0%US$18.2M+369KNov 16, 2026
Geode Capital1.91M2.4%US$14.7M−37,035Nov 6, 2026
Royce & Associates LP1.66M2.1%US$12.8M−516KNov 9, 2026
Oberweis Asset Management Inc/1.32M1.7%US$10.2M−1,345Nov 16, 2026
Goldman Sachs1.25M1.6%US$9.62M+783KNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Marshall Wace, LLP1.2M1.5%US$9.2M+416KNov 13, 2026
Alyeska Investment Group, L.P.850K1.1%US$6.54MNo changeNov 16, 2026
Armistice Capital, LLC836K1.1%US$6.44M+336KNov 16, 2026
Trexquant Investment LP719K0.90%US$5.54M+95,351Nov 16, 2026
Northern Trust718K0.90%US$5.53M−38,134Nov 16, 2026
Morgan Stanley641K0.81%US$4.94M+218KNov 13, 2026
Schwab616K0.77%US$4.75M−1,870Nov 16, 2026
Hrt Financial LP610K0.77%US$4.7M−15,330Nov 13, 2026
Hennion & Walsh Asset Management, Inc.537K0.68%US$4.13M+98,280Oct 13, 2026
Bridgeway Capital Management, LLC459K0.58%US$3.54M+25,091Nov 16, 2026
Kennedy Capital Management LLC408K0.51%US$3.14M−11,581Nov 13, 2026
BNY372K0.47%US$2.87M−23,633Nov 5, 2026
Raymond James Financial Inc359K0.45%US$2.76M−87,095Nov 12, 2026
First Trust343K0.43%US$2.64M+295KNov 12, 2026
D. E. Shaw & Co., Inc.330K0.42%US$2.54M+159KNov 16, 2026
Ameriprise275K0.35%US$2.11M−1,784Nov 16, 2026
Empowered Funds, LLC268K0.34%US$2.07M+25,091Nov 13, 2026
Wellington263K0.33%US$2.03M+47,611Nov 16, 2026
JPMorgan263K0.33%US$2.08M+195KNov 12, 2026
Steward Partners Investment Advisory, LLC234K0.29%US$1.8M+1,677Nov 13, 2026
Principal218K0.27%US$1.68M+26,998Nov 2, 2026
Commonwealth Equity Services, LLC212K0.27%US$1.63M−2,725Nov 2, 2026
Quantinno Capital Management LP198K0.25%US$1.52M+57,530Nov 13, 2026
Nuveen183K0.23%US$1.41M−1,846Nov 10, 2026
Two Sigma175K0.22%US$1.35M+134KNov 16, 2026
Susquehanna175K0.22%US$1.34M−144KNov 16, 2026
Bank of America158K0.20%US$1.22M+7,806Nov 16, 2026
Private Advisor Group, LLC155K0.19%US$1.19M−261KNov 10, 2026
Swiss National Bank147K0.18%US$1.13M+8,000Nov 12, 2026
Wingate Wealth Advisors, Inc.128K0.16%US$986K−500Oct 26, 2026
Profund Advisors LLC127K0.16%US$981K+105KOct 28, 2026
Palisades Investment Partners, LLC122K0.15%US$941K−304KNov 3, 2026
Credit Agricole S A104K0.13%US$801KNo changeNov 13, 2026
Franklin Templeton101K0.13%US$573K+77,739Nov 12, 2026
West Michigan Advisors, LLC97,5000.12%US$751K+31,500Nov 9, 2026
LPL Financial LLC94,1910.12%US$725K−43,975Nov 6, 2026
Rhumbline Advisers90,7590.11%US$699K−3,179Nov 10, 2026
Corient Private Wealth LP90,4720.11%US$697K−5,468Nov 16, 2026
AQR Capital Management LLC86,5170.11%US$666K−64,918Nov 16, 2026
Magnetar Financial LLC85,3420.11%US$657K+48,825Nov 13, 2026

This page holds 50 of 181 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund2.23M2.8%US$17.5MNo changeJun 30, 2026
iShares Russell 2000 ETF1.94M2.4%US$15.2M+89,431Jun 30, 2026
Oberweis Micro-Cap Fund1.28M1.6%US$10M−22,154Jun 30, 2026
Vanguard Extended Market Index Fund824K1.0%US$6.47M−5,022Jun 30, 2026
Fidelity Small Cap Index Fund817K1.0%US$6.15M+80,240Jul 31, 2026
iShares Russell 2000 Value ETF683K0.86%US$5.36MNewJun 30, 2026
Pacer US Small Cap Cash Cows 100 ETF626K0.79%US$4.71M+51,118Jul 31, 2026
Royce Small-Cap Opportunity Fund567K0.71%US$4.45M+150KJun 30, 2026
Royce Small-Cap Fund563K0.71%US$4.42M−40,772Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF550K0.69%US$4.32M−4,502Jun 30, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Fidelity Extended Market Index Fund381K0.48%US$3.22M−4,232May 31, 2026
Vanguard Russell 2000 Index Fund381K0.48%US$3.22M+13,162May 31, 2026
Schwab U.S. Small-Cap ETF348K0.44%US$2.94M−5,450May 31, 2026
iShares Micro-Cap ETF251K0.32%US$1.97M+63,600Jun 30, 2026
Royce Capital Fund - Small-Cap Portfolio245K0.31%US$1.92M−39,617Jun 30, 2026
EA Bridgeway Omni Small-Cap Value ETF243K0.31%US$1.91MNewJun 30, 2026
Vanguard Health Care Index Fund221K0.28%US$1.86M−1,872May 31, 2026
VictoryShares Small Cap Free Cash Flow ETF203K0.26%US$1.59M−289KJun 30, 2026
iShares U.S. Pharmaceuticals ETF190K0.24%US$1.49M−14,641Jun 30, 2026
Omni Small-Cap Value Fund190K0.24%US$1.49MNewJun 30, 2026
Principal U.S. Small-Cap ETF187K0.24%US$1.47M+13,334Jun 30, 2026
Schwab Small-Cap Index Fund181K0.23%US$1.37M+16,777Jul 31, 2026
Auer Growth180K0.23%US$1.52MNo changeMay 31, 2026
Royce Small-Cap Value Fund147K0.18%US$1.15M−18,570Jun 30, 2026
Master Small Cap Index Series139K0.18%US$1.09M+19,620Jun 30, 2026
Fidelity Total Market Index Fund136K0.17%US$1.15MNo changeMay 31, 2026
WisdomTree U.S. SmallCap Fund119K0.15%US$936K−2,802Jun 30, 2026
Fidelity Series Total Market Index Fund112K0.14%US$943K+4,664May 31, 2026
Fidelity Small Cap Value Index Fund104K0.13%US$819KNewJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF100K0.13%US$787K+2,448Jun 30, 2026
Nuveen Small Cap Blend Index Fund99,0680.12%US$746K+10,038Jul 31, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF96,0060.12%US$810K+39,266May 31, 2026
EQ/2000 Managed Volatility Portfolio80,5960.10%US$633K+247Jun 30, 2026
Easterly Snow Long/Short Opportunity Fund76,0000.10%US$641KNewMay 31, 2026
Nuveen Equity Index Fund74,1140.09%US$558KNo changeJul 31, 2026
Small Cap Value Fund71,3010.09%US$560KNewJun 30, 2026
Vanguard Russell 2000 Growth Index Fund70,0360.09%US$591K+1,986May 31, 2026
Vanguard U.S. Multifactor ETF69,6530.09%US$588K−29,859May 31, 2026
Schwab Total Stock Market Index Fund48,6040.06%US$366KNo changeJul 31, 2026
LVIP State Street Small-Cap Index Fund47,5000.06%US$373KNo changeJun 30, 2026
Fidelity Nasdaq Composite Index Fund46,0450.06%US$389KNo changeMay 31, 2026
First Trust Active Factor Small Cap ETF44,0700.06%US$372K+17,807May 31, 2026
Schwab U.S. Broad Market ETF40,6730.05%US$343K+479May 31, 2026
Fidelity ZERO Total Market Index Fund39,4010.05%US$297K+1,581Jul 31, 2026
Vanguard Balanced Index Fund39,2640.05%US$308KNo changeJun 30, 2026
Small Cap Index Fund38,3780.05%US$301K+5,869Jun 30, 2026
EQ/Small Company Index Portfolio35,9100.05%US$282KNo changeJun 30, 2026
Global X Russell 2000 ETF35,6130.04%US$268K+3,481Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund33,1280.04%US$260KNo changeJun 30, 2026
Fidelity MSCI Health Care Index ETF31,4790.04%US$237K−2,525Jul 31, 2026

This page holds 50 of 134 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Blum Susan
Officer: Chief Financial Officer
Buy5,000USD 4.58US$22,900Nov 19, 2026
Lefkowitz Steven W
Director
Buy11,500USD 4.53US$52,095Nov 18, 2026
Kaplan Myron
Director
Buy25,000USD 4.88US$122KNov 16, 2026
Todisco Joseph
Director, Officer: Chief Executive Officer
Buy80,000USD 4.89US$391KNov 13, 2026

Big stakes

HolderStakeSharesDate
Deep Track Capital, LP7.94%6.27MMar 31, 2026
BlackRock, Inc.7.50%4.57MDec 31, 2024
SHAIBATALHAMD AYMEN ABDALKADER5.90%4.62MJun 11, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alan W. Dunton
Other companies: Palatin Technologies, Inc. (Director · Since at least Jun 22, 2011); Oragenics Inc. (Director · Since at least Apr 1, 2011); Adams Respiratory Therapeutics Inc (Director · Nov 8, 2006 – Jan 29, 2008 · Past); Gyre Therapeutics, Inc. (Director · Oct 18, 2006 – Aug 14, 2015 · Past); MediciNova, Inc. (Director · May 11, 2006 – Jun 11, 2010 · Past)
Director · Since at least Mar 1, 2019
Bami Bastani
Other companies: Aquantia Corp (Director · Nov 2, 2017 – Jun 19, 2019 · Past); Meru Networks Inc (President & CEO, Director · Mar 21, 2012 – Jul 8, 2015 · Past); ANADIGICS Inc (CEO, Director · Apr 27, 2007 – Jul 25, 2008 · Past); TaoWeave, Inc. (Director · Apr 23, 2007 – May 28, 2009 · Past)
Director · Mar 24, 2010 – Jan 14, 2011 · Past
Richard Cohen
Other companies: Direct Digital Holdings, Inc. (Director · Since at least Feb 15, 2022); Blue Biofuels, Inc. (CFO · Jan 21, 2014 – Jan 21, 2014 · Past); Dominari Holdings Inc. (Chief Financial Officer · Jan 6, 2014 – Jan 6, 2014 · Past); Direct Markets Holdings Corp (Director · Aug 13, 2007 – Jul 2, 2012 · Past)
Chief Financial Officder, Director · Mar 24, 2010 – Mar 20, 2013 · Past
Robert W Cook
Other companies: Elite Express Holding Inc. (See Remarks · Since at least Aug 20, 2025); MELA Sciences Inc (Chief Financial Officer · Apr 14, 2014 – Feb 3, 2015 · Past); Immune Pharmaceuticals Inc (CFO and Senior VP, Director · Feb 3, 2014 – Feb 3, 2014 · Past)
Chief Financial Officer · Feb 1, 2017 – Sep 30, 2019 · Past
Cora M Tellez
Other companies: Pacific Premier Bancorp Inc (Director · Oct 3, 2015 – Mar 15, 2022 · Past); HMS Holdings Corp (Director · Jun 30, 2015 – Mar 31, 2021 · Past)
Director · Aug 14, 2015 – May 30, 2017 · Past
Joseph Todisco
Other companies: Talphera, Inc. (Director · Since at least Oct 14, 2025); Amneal Pharmaceuticals, Inc. (Executive Vice President · May 7, 2019 – May 7, 2022 · Past)
Chief Executive Officer, Director · Since at least Mar 18, 2022
Khoso Baluch
Other companies: Longeveron Inc. (Director · Since at least Jun 9, 2023); Processa Pharmaceuticals, Inc. (Member · Since at least Jul 11, 2022)
Chief Executive Officer, Director · Oct 3, 2016 – Jan 11, 2021 · Past
Paulo F Costa
Other companies: MacroGenics, Inc. (Director · Oct 9, 2013 – May 13, 2021 · Past); Amylin Pharmaceuticals LLC (Director · Jun 9, 2009 – Aug 8, 2012 · Past)
Director · Sep 15, 2020 – May 17, 2023 · Past
Susan Blum
Other companies: BiomX Inc. (Director · Apr 11, 2024 – Apr 14, 2025 · Past); Melinta Therapeutics Inc (VP of Finance & CAO · Oct 17, 2019 – Oct 17, 2019 · Past)
EVP & Chief Financial Officer · Since at least Aug 29, 2025
Taunia Markvicka
Other companies: Statera Biopharma, Inc. (Chief Operating Officer, Director · Sep 28, 2021 – Sep 28, 2021 · Past); Pacira BioSciences, Inc. (SVP, Chief Commercial Officer · Mar 21, 2012 – Mar 17, 2015 · Past)
Director · Apr 4, 2014 – May 15, 2017 · Past
All 39 people
PersonSeat
Greg Duncan
Other companies: Dogwood Therapeutics, Inc. (Chief Executive Officer & Chairman of the Board of Directors · Since at least Oct 19, 2026)
Director · Since at least Nov 4, 2026
Gregory Scott Duncan
Other companies: Dogwood Therapeutics, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Dec 16, 2020)
Director · Since at least Nov 2, 2020
James Lefkowitz
Other companies: Digital Turbine, Inc. (President · Jun 28, 2007 – Mar 16, 2009 · Past)
Director · Dec 15, 2011 – Dec 15, 2011 · Past
Joe Todisco
Other companies: Talphera, Inc. (Director · Oct 21, 2025 – Nov 4, 2026 · Past)
Chief Executive Officer and Chairman · Since at least Mar 5, 2026
Judith R Abrams
Other companies: Editas Medicine, Inc. (Chief Medical Officer · Oct 28, 2019 – Oct 28, 2019 · Past)
Chief Medical Officer · Feb 1, 2017 – Feb 1, 2017 · Past
Matthew T David
Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Chief Financial Officer · Since at least Oct 14, 2026)
Chief Financial Officer · May 11, 2020 – Jan 10, 2025 · Past
Randy Milby
Other companies: Canton Strategic Holdings, Inc. (CEO, Director · Jan 11, 2022 – Jan 13, 2025 · Past)
Chief Executive Officer, Director · May 14, 2012 – Aug 10, 2016 · Past
Robert Stewart
Other companies: Amneal Pharmaceuticals, Inc. (President and CEO, Director · May 4, 2018 – May 7, 2019 · Past)
Director · Since at least Apr 13, 2023
Steven W Lefkowitz
Other companies: Franklin Credit Management Corp. (Director · Oct 12, 2012 – May 24, 2013 · Past)
Director · Since at least Aug 11, 2011
Antony PfaffleChief Scientific Officer · Mar 24, 2010 – Feb 7, 2017 · Past
Beth Zelnick KaufmanEVP, Chief Legal and Compliance Officer, and Corporate Secretary · Since at least Sep 2, 2025
Elizabeth HurlburtChief Operating Officer · Since at least Mar 19, 2018
Erin MistryEVP, Chief Commercial Officer · Jan 14, 2023 – Jan 10, 2025 · Past
Gary A GelbfishDirector · Mar 24, 2010 – Jan 10, 2019 · Past
Harry O'GradyChief Financial Officer · Jul 21, 2014 – Jul 21, 2014 · Past
Janet D. DillioneDirector · Since at least Nov 14, 2017
John L Armstrong JrExec VP of Tech Operations · Mar 1, 2017 – Jan 11, 2021 · Past
Kaufman Beth ZelnickChief Legal Officer · Since at least Dec 12, 2023
Liz HurlburtEVP, Chief Operating & Commercial Officer · Since at least Sep 2, 2025
Mark A KlausnerChief Medical Officer · Mar 1, 2011 – Mar 1, 2011 · Past
Mark T HouserChief Medical Officer · Mar 24, 2010 – Nov 26, 2010 · Past
Matthew DuffyDirector · Nov 21, 2011 – Jun 3, 2016 · Past
Michael David SecklerChief Commercial Officer · Since at least Jan 8, 2026
Mike SecklerEVP & Chief Commercial Officer · Since at least Jan 8, 2026
Myron KaplanLead Independent Director · Since at least Apr 27, 2016
Phoebe MountsGeneral Counsel · May 1, 2019 – Jan 14, 2023 · Past
Steven LefkowitzDirector · Since at least Nov 4, 2026
Thomas NusbickelEVP, Chief Commercial Officer · May 13, 2021 – Feb 18, 2022 · Past
Timothy M HoferDirector · Mar 24, 2010 – Jan 6, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about CorMedix Inc.